Table 3.

Comparison of TAS, TOS, OSI and AOPP levels in the patient group according to family history, rosacea type, symptoms and ocular involvement (mean ± standard deviation, median (Q1–Q3))

Parameter	Family history			P-value
	Negative		Positive
TAS	2.40 ±0.26 2.41 (2.21–2.60)		2.41 ±0.25 2.46 (2.20–2.59)	0.936*
TOS	3.72 ±2.18 3.20 (2.63–4.52)		3.58 ±1.18 3.42 (2.64–4.17)	0.862†
AOPP	105.23 ±68.42 93.85 (46.76–161.78)		93.87 ±82.41 72.93 (41.49–111.15)	0.287†
OSI	15.47 ±8.02 13.60 (10.98–18.64)		14.78 ±4.17 14.22 (11.45–17.31)	0.911†
Parameter	Rosacea type			P-value
	Erythematotelangiectatic		Papulopustular
TAS	2.35 ±0.28 2.35 (2.13–2.59)		2.43 ±0.24 2.47 (2.22–2.61)	0.266*
TOS	3.75 ±1.44 3.63 (2.51–4.87)		3.64 ±2.07 3.17 (2.67–4.22)	0.519†
AOPP	110.21 ±94.57 83.32 (36.60–175.93)		97.26 ±61.63 92.39 (46.46–128.28)	0.980†
OSI	15.81 ±5.38 15.85 (11.29–19.88)		14.97 ±7.56 13.24 (11.01–17.11)	0.250†
>Parameter	Symptoms			P-value
	No symptom	Only one symptom	More than one symptom
TAS	2.36 ±0.30 2.39 (2.11–2.60)	2.38 ±0.23 2.42 (2.21–2.58)	2.43 ±0.26 2.49 (2.21–2.62)	0.647‡
TOS	4.31 ±4.09 3.12 (2.68–3.86)	3.33 ±1.32 3.10 (2.39–3.90)	3.74 ±1.17 3.45 (2.96–4.80)	0.317§
AOPP	124.02 ±58.03 111.24 (86.94–178.36)	98.07 ±73.25 73.06 (42.62–138.21)	97.18 ±77.42 93.54 (33.95–134.35)	0.296§
OSI	17.39 ±13.72 13.28 (11.99–17.51)	14.01 ±5.30 13.08 (10.21–16.95)	15.49 ±5.00 13.98 (11.75–19.73)	0.528§
Parameter	Ocular involvement			P-value
	Negative		Positive
TAS	2.38 ±0.25 2.42 (2.20–2.58)		2.48 ±0.25 2.47 (2.33–2.69)	0.179*
TOS	3.70 ±2.06 3.26 (2.58–4.47)		3.58 ±0.98 3.34 (2.85–4.33)	0.758†
AOPP	101.02 ±73.17 93.56 (41.15–155.57)		102.57 ±75.64 78.91 (53.41–113.40)	0.883†
OSI	15.48 ±7.59 13.70 (11.01–18.33)		14.27 ±3.06 14.19 (11.56–15.65)	0.883†

^*Independent samples t-test,

^†Mann-Whitney U test,

^‡One way analysis of variance analysis,

^§Kruskal Wallis H test.